History has a frustrating way of repeating itself in public health. Currently, as we monitor reports of Andes Hantavirus, a disturbing pattern is emerging: a hesitation to adopt the precautionary principle despite the devastating lessons of SARS-1 in 2003 and the COVID-19 pandemic.
The Current Conflict in Guidance
On May 8th, the World Health Organization (WHO) issued recommendations for healthcare workers managing suspected Andes Hantavirus cases. Despite a mortality risk as high as 40% to 50%, the WHO is currently advising “standard respiratory precautions”—recommending simple medical masks rather than N95 or FFP2/3 respirators.
This guidance remains in place until airborne transmission is “proven,” a stance that contradicts the advice from the U.S. Centers for Disease Control (CDC) and the European Centre for Disease Prevention and Control (ECDC), both of which have already moved to recommend N95 respirators for these frontline workers.
A Costly History of Delay
This debate isn’t new. We have seen the consequences of “waiting for proof” before:
- SARS-1 (2003): In Toronto, the virus primarily devastated healthcare workers and their families. It was only after universal N95 respirator use was implemented in April 2003 that the spread was successfully curtailed.
- The Campbell Report: Following SARS-1, Justice Archie Campbell’s commission stated a vital rule for Canadian healthcare: Presume airborne transmission until proven otherwise.
- COVID-19 (2020): We saw a multi-year delay in acknowledging the airborne nature of COVID-19, a delay that WHO officials later admitted resulted in an enormous, preventable loss of life.
Why Andes Hantavirus is Different
Recent evidence, including a 2020 report in the New England Journal of Medicine, suggests that the Andes Hantavirus variant—the same one currently linked to cruise ship exposures—may be capable of airborne spread. Reports of transmission during short, public exposures like birthday parties and wakes challenge the traditional narrative that this virus only spreads through prolonged, close contact.
Protecting the System and the Patient
In the Canadian healthcare context, we know that protecting our healthcare workers is the only way to ensure the system remains accessible for everyone. By failing to recommend the highest level of respiratory protection for a virus with such a high mortality rate, we risk unnecessary exposure for staff and the potential for wider community outbreaks.
We must stop “hoping for the best” and start planning for the reality of viral transmission. The precautionary principle is not just a clinical suggestion; it is an ethical necessity to prevent the next pandemic from gaining a foothold.
There is currently no vaccination against hantavirus.
Stay Connected with Destinations Travel and Immunization Clinic! healthytrip.ca/travel-blog
Because Your Health Doesn’t Take a Vacation — Even When You Do.
If you found this article helpful, don’t forget to like, share, and Follow to stay up to date on our latest travel health tips, updates, and wellness advice.
The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your health care provider first. Full Disclaimer